Your browser doesn't support javascript.
loading
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study.
Landis, Megan N; Smith, Stacy R; Berstein, Gabriel; Fetterly, Gerald; Ghosh, Pranab; Feng, Gang; Pradhan, Vivek; Aggarwal, Sudeepta; Banfield, Christopher; Peeva, Elena; Vincent, Michael S; Beebe, Jean S; Tarabar, Sanela.
Afiliación
  • Landis MN; Department of Medicine (Dermatology), University of Louisville School of Medicine, Louisville, KY, USA.
  • Smith SR; Dermatology and Skin Cancer Center of South Indiana, Corydon, IN, USA.
  • Berstein G; California Dermatology and Clinical Research Institute, Encinitas, CA, USA.
  • Fetterly G; Pfizer Inc., Cambridge, MA, USA.
  • Ghosh P; Pfizer Inc., Cambridge, MA, USA.
  • Feng G; Pfizer Inc., Cambridge, MA, USA.
  • Pradhan V; Pfizer Inc., Cambridge, MA, USA.
  • Aggarwal S; Pfizer Inc., Cambridge, MA, USA.
  • Banfield C; Pfizer Inc., Cambridge, MA, USA.
  • Peeva E; Pfizer Inc., Cambridge, MA, USA.
  • Vincent MS; Pfizer Inc., Cambridge, MA, USA.
  • Beebe JS; Pfizer Inc., Cambridge, MA, USA.
  • Tarabar S; Pfizer Inc., Cambridge, MA, USA.
Br J Dermatol ; 189(1): 33-41, 2023 07 07.
Article en En | MEDLINE | ID: mdl-36972293

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Inhibidores de las Cinasas Janus Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Inhibidores de las Cinasas Janus Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos